• Glenmark launches Ryaltris-AZ in India expresspharma
    May 07, 2021
    Glenmark Pharmaceuticals announced the launch of Ryaltris-AZ Nasal Spray, a novel fixed-dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg, for the treatment of moderate to severe allergic rhinitis, in India.
PharmaSources Customer Service